HemaSphere (Aug 2023)

P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL)

  • Michael Loschi,
  • Laszlo Rejto,
  • Hun Chuah,
  • Marianna Caramella,
  • Jesus Hernández Rivas,
  • Paolo Sportoletti,
  • Viviane Dubruille,
  • Marcelo Bellesso,
  • Stefanie Gröpper,
  • Carl Crodel,
  • Hope Qamoos,
  • Ashley Socotch,
  • Zhuying Huang,
  • Sarah Wall,
  • Jesse Mcgreivy,
  • Wayne P. Rothbaum,
  • Srdan Verstovsek,
  • Francesca Palandri

DOI
https://doi.org/10.1097/01.HS9.0000971048.09624.cd
Journal volume & issue
Vol. 7
p. e09624cd

Abstract

Read online

No abstracts available.